“Within the next several months, the court will be closing the Risperdal, Essure and Elmiron mass tort programs, as the lawyers and self-represented parties work through the remaining cases on the docket,” Judge Joshua Roberts, head of the Philadelphia Court of Common Pleas Complex Litigation Center, said.

Click Here To Read The Full Article